TechAmerica
SearchSubscribe

Biotechnology

23 articles · page 1 of 2 · showing 1 to 12

Biotechnology, newest first

  1. Proximal Ventures fund
    Venture

    Proximal Ventures Raises $27.5M Fund for AI Drug Development

    Proximal Ventures, founded by former SignalFire investor Sahir Raoof, has closed its debut fund at $27.5 million. The firm will back early-stage startups using AI to improve drug discovery, clinical trials, pharmaceutical manufacturing and related services.

    By Shivangi Yadav2 min read
  2. Water molecules can influence whether an experimental drug binds successfully to its intended target. Predicting where those molecules sit inside a protein is a difficult computational problem, and researchers are now testing whether quantum computers
    Biotech & Health

    Quantum Computing in Drug Discovery: What Is Possible?

    Quantum computing in drug discovery could help researchers simulate molecular interactions, investigate chemical reactions, and identify promising drug candidates. Explore how quantum…

    By Rui Huang9 min read
  3. Warhound military dogs
    Startups

    Warhound military dogs venture raises $200M for gene editing

    Warhound has emerged from stealth with $200 million in funding at a $1.2 billion valuation. Backed by Ben Lamm and Palmer Luckey, the startup plans to develop genetically enhanced military…

    By Shivangi Yadav3 min read
  4. Laboratory glassware and liquid-filled flasks on a modern research bench, illustrating Warp Sciences funding
    Brief

    Warp Sciences funding hits $215M for robotic drug labs

    Former OpenAI science leader Kevin Weil has launched Warp Sciences with $215 million in funding at an $865 million valuation. The startup plans to use AI-trained robots to automate chemical…

    By Shivangi Yadav2 min read
  1. Image Credit: TechAmerica.ai / AI-generated image
    Biotech & Health

    AI Is Starting to Reshape Clinical Trials

    AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.

    By Keshav Khandelwal9 min read

Newsletters

The day's tech news, in five minutes

Written by the reporters who cover each beat. No sponsored stories, and you can unsubscribe in one click.

Send me

By subscribing you agree to our Terms and Privacy policy.

Thank you

Your newsletter subscription has been received. Thank you for subscribing to TechAmerica.ai.